554 related articles for article (PubMed ID: 33826705)
1. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[TBL] [Abstract][Full Text] [Related]
3. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
[TBL] [Abstract][Full Text] [Related]
4. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
[TBL] [Abstract][Full Text] [Related]
5. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
Cooper JC; Rouster-Stevens K; Wright TB; Hsu JJ; Klein-Gitelman MS; Ardoin SP; Schanberg LE; Brunner HI; Eberhard BA; Wagner-Weiner L; Mehta J; Haines K; McCurdy DK; Phillips TA; Huang Z; von Scheven E;
Pediatr Rheumatol Online J; 2018 Oct; 16(1):65. PubMed ID: 30348175
[TBL] [Abstract][Full Text] [Related]
6. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Hailu GT; Hussen SU; Getachew S; Berha AB
BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
9. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
Jin SY; Huang DL; Dang XQ; Yi ZW
Paediatr Int Child Health; 2017 Nov; 37(4):286-291. PubMed ID: 28463080
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
Basu B; Roy B; Babu BG
Pediatr Nephrol; 2017 Jun; 32(6):1013-1021. PubMed ID: 28191596
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
Chbihi M; Eveillard LA; Riller Q; Brousse R; Berthaud R; Quartier P; Salomon R; Charbit M; Avramescu M; Biebuyck N; Dehoux L; Garcelon N; Duong-Van-Huyen JP; Bader-Meunier B; Boyer O
J Nephrol; 2023 Apr; 36(3):829-839. PubMed ID: 36208405
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological features and short-term outcomes of lupus nephritis: a prospective study of 100 Egyptian patients.
Saleh M; Eltoraby EE; Tharwat S; Nassar MK
Lupus; 2020 Jul; 29(8):993-1001. PubMed ID: 32493152
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients.
Rosli FZ; Shaharir SS; Abdul Gafor AH; Mohd R; Aizuddin AN; Osman S
Lupus; 2022 Aug; 31(9):1138-1146. PubMed ID: 35608373
[TBL] [Abstract][Full Text] [Related]
14. Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India.
Biswas D; Dasgupta D; Pal P; Sinha R
Lupus; 2023 Oct; 32(12):1440-1446. PubMed ID: 37707867
[TBL] [Abstract][Full Text] [Related]
15. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
Groot N; de Graeff N; Marks SD; Brogan P; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Özen S; Pilkington CA; Ravelli A; Royen-Kerkhof AV; Uziel Y; Vastert BJ; Wulffraat NM; Beresford MW; Kamphuis S
Ann Rheum Dis; 2017 Dec; 76(12):1965-1973. PubMed ID: 28877866
[TBL] [Abstract][Full Text] [Related]
16. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
Baskin E; Ozen S; Cakar N; Bayrakci US; Demirkaya E; Bakkaloglu A
Pediatr Nephrol; 2010 Jan; 25(1):111-7. PubMed ID: 19727839
[TBL] [Abstract][Full Text] [Related]
17. A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
Gul H; Mushtaq MS; Salim B; Samreen S; Nasim A; Khan M
J Ayub Med Coll Abbottabad; 2020; 32(4):454-458. PubMed ID: 33225643
[TBL] [Abstract][Full Text] [Related]
18. Rituximab use as induction therapy for lupus nephritis: a systematic review.
Stolyar L; Lahita RG; Panush RS
Lupus; 2020 Jul; 29(8):892-912. PubMed ID: 32486934
[TBL] [Abstract][Full Text] [Related]
19. International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24 months.
De Mutiis C; Wenderfer SE; Basu B; Bagga A; Orjuela A; Sar T; Aggarwal A; Jain A; Yap HK; Teo S; Ito S; Ohnishi A; Iwata N; Kasapcopur O; Yildiz M; Laurent A; Mastrangelo A; Ogura M; Shima Y; Rianthavorn P; Silva CA; Trindade V; Gianviti A; Akinori M; Hamada R; Fujimura J; Minamikawa S; Kamiyoshi N; Kaito H; Ishimori S; Iannuzzella F; Tullus K
Pediatr Nephrol; 2023 Nov; 38(11):3699-3709. PubMed ID: 37221349
[TBL] [Abstract][Full Text] [Related]
20. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.
Al Arfaj AS; Khalil N; Al Saleh S
Rheumatol Int; 2009 Jul; 29(9):1057-67. PubMed ID: 19381639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
